Loading...
  • Market
  • This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. (marketsandmarkets.com)
  • In the U.S., the in situ hybridization market is driven by increasing government initiatives, growing biomedical research, rising prevalence of cancer, and growing demand for companion diagnostics and personalized medicine. (marketsandmarkets.com)
  • In the coming years, the in situ hybridization market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on India, China, and Japan. (gii.co.jp)